Penumbra, Inc. is a healthcare company.
Penumbra, Inc. (PEN) is expected to report earnings on Wednesday, November 4, 2026, after the close. Estimated release time 16:14 ET. Consensus EPS estimate is $1.20.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-30 | Jun 2026 qtr | $1.16 | $0.88 | — | $390.05M |
| 2026-05-06 | Mar 2026 qtr | $1.04 | $0.83 | — | $374.76M |
| 2026-02-25 | Dec 2025 qtr | $1.11 | $1.21 | +9.0% | $385.38M |
| 2025-11-05 | Sep 2025 qtr | $0.93 | $1.17 | — | $354.69M |
| 2025-07-29 | Jun 2025 qtr | $0.81 | $1.17 | — | $339.45M |
| 2025-04-23 | Mar 2025 qtr | $0.66 | $1.02 | — | $324.14M |
| 2025-02-18 | Dec 2024 qtr | $0.88 | $0.88 | +0.0% | $315.52M |
| 2024-10-30 | Sep 2024 qtr | $0.69 | $0.76 | +10.1% | $301.04M |
PEN has beaten consensus EPS in 3 of its last 3 scored quarters.
See PEN on the live calendar →